Tilray: Canaccord Reiterates US$12 Price Target After Distillery Purchase

On December 8th, Tilray (TSX: TLRY) announced the acquisition of Breckenridge Distillery, a whiskey and craft spirits seller. The company will be paying $102.9 million through the issuance of 11,245,511 Tilray shares. The company says that this acquisition will be immediately accretive to their adjusted EBITDA, but provide no additional financial colour other than the company’s adjusted EBITDA margin is “approximately 25 percent.”

Tilray positions this acquisition as a way to “commercialize new and innovative products” of infused cannabis drinks when federally permissible.

Tilray currently has 20 analysts covering the stock with an average 12-month price target of US$12.74, or a 43% upside to the current stock price. Out of the 20 analysts, 1 has a strong buy rating, 2 have buy ratings, 14 have hold ratings, and the last 3 analysts have to sell ratings on Tilray. The street high comes in at US$23 from Cowen and Company while the lowest sits at US$0.82 from GLJ Research.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

In Canaccord’s review of the purchase, they reiterate their US$12 12-month price target and hold rating, saying that at face value the acquisition “could represent an attractive addition to the company’s overall US CPG footprint.” Although they warn the ability to actually leverage an alcoholic beverage company into any sort of THC-exposure asset.

Canaccord says that since Breckenridge Distillery derives roughly 85% of its revenue from Colorado, it will help strengthen its US footprint and will be able to use SweetWater to increase its exposure and product development throughout the United States.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Goliath Extends Golden Gate Lode 130 Metres With 13.45 g/t Gold Equivalent Over 4.85 Metres

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Related News

Curaleaf: Haywood Reiterates $22 Price Target, Names Firm A Top Pick For 2022

On December 28th, Curaleaf Holdings (CSE: CURA) announced that they have entered into a definitive agreement...

Friday, December 31, 2021, 04:35:00 PM

Trulieve: Analysts Raise Price Targets Following Q4 Results

Yesterday, Trulieve Cannabis (CSE: TRUL) announced their fourth quarter and year-end financial for 2020. The...

Saturday, March 27, 2021, 02:45:00 PM

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM

Valens: Analysts Reiterate Price Targets, Ratings Following Q3 Results

Last week, The Valens Company (TSX: VLNS) reported their third-quarter results. Revenues were stable quarter...

Tuesday, October 20, 2020, 12:19:00 PM

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM